0001209191-19-045633.txt : 20190812 0001209191-19-045633.hdr.sgml : 20190812 20190812190847 ACCESSION NUMBER: 0001209191-19-045633 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190808 FILED AS OF DATE: 20190812 DATE AS OF CHANGE: 20190812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Popovits Kimberly J CENTRAL INDEX KEY: 0001333482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 191017952 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-08 0 0001131324 GENOMIC HEALTH INC GHDX 0001333482 Popovits Kimberly J 301 PENOBSCOT DR. REDWOOD CITY CA 94063 1 1 0 0 President and CEO Common Stock 2019-05-29 5 G 0 E 800 0.00 D 108152 I Held by the Popovits 2010 Trust Common Stock 2019-08-08 4 M 0 25000 29.34 A 133468 I Held by the Popovits 2010 Trust Common Stock 2019-08-08 4 S 0 15765 73.6312 D 117703 I Held by the Popovits 2010 Trust Common Stock 2019-08-08 4 S 0 9235 74.2252 D 108468 I Held by the Popovits 2010 Trust Common Stock 2019-08-09 4 M 0 25000 29.34 A 133468 I Held by the Popovits 2010 Trust Common Stock 2019-08-09 4 S 0 24000 73.6322 D 109468 I Held by the Popovits 2010 Trust Common Stock 2019-08-09 4 S 0 1000 74.3691 D 108468 I Held by the Popovits 2010 Trust Common Stock 12298 I Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits Common Stock 36168 D Employee Stock Option (right to buy) 29.34 2019-08-08 4 M 0 25000 0.00 D 2022-02-05 Common Stock 25000 65000 D Employee Stock Option (right to buy) 29.34 2019-08-09 4 M 0 25000 0.00 D 2022-02-05 Common Stock 25000 40000 D These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $73.03 to $74.02. Represents weighted average sale price. Actual sale prices ranged from $74.03 to $74.39. Represents weighted average sale price. Actual sale prices ranged from $73.24 to $74.15. Represents weighted average sale price. Actual sale prices ranged from $74.24 to $74.45. Represents shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. The option became exercisable as to 25% of the shares on February 5, 2013, and became exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2019-08-12